This is a $93,300.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Cisbio US, Inc., a foreign-owned for-profit company, for the provision of 10,000 HISTONE2 HTRF Assay test kits. The award was not set aside. Cisbio US, Inc. has previously provided assay kits, cell lines, and collagen reagents related to disease research to various Department of Health and Human Services (HHS) agencies, including the NIH, Centers for Disease Control and...
This federal contract award, HHSN271201500631P, was made by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS), to Cisbio US, Inc., a foreign-owned for-profit company. The $84,700 firm-fixed-price purchase order contract is for the provision of assay kits and reagents, including those used to detect biomarkers related to disease research, as well as cell lines and collagen reagents. The contract has a total small business...
This federal contract award is for the provision of custom reagents for a Homogeneous Time-Resolved Fluorescence (HTRF) assay, with a ceiling value of $18,700.00. The contract was awarded to Cisbio US, Inc., a foreign-owned for-profit organization that provides assay kits and reagents to the U.S. federal government, particularly the Department of Health and Human Services (HHS) and its agencies such as the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and...
This federal contract award, with an ID of HHSN271201500432P, was issued by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), to Cisbio US, Inc., a foreign-owned for-profit company. The $128,330.00 firm-fixed-price purchase order contract was set aside for a small business. It was awarded on July 21, 2015, with an ultimate completion date of August 21, 2015. Based on Cisbio US, Inc.'s past federal contract experience, the contract...
This federal contract award, valued at $15,656.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services (HHS). The prime contractor is Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions for the biopharmaceutical and life sciences industries. The contract does not have a set-aside designation. Under this award, Sartorius Corporation will provide...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed price purchase order to Fisher Scientific Company L.L.C. valued at $24,010.95 to provide multiple formulation-related laboratory tools and equipment. The solicitation requested brand name or equal laboratory items to support the agency's research and development efforts. Performance will take place in Potomac, Maryland over a three-month period...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $12,472 firm fixed price purchase order to Proteinsimple, a division of Bio-Techne Corporation doing business as Bio-Techne, to provide protein analysis services and equipment. The place of performance is in Potomac, Maryland through October 13, 2023. As part of NIH's efforts to advance translational sciences and support, this award will enable Proteinsimple to...
This is a $127,908.40 firm fixed-price purchase order awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The award is for Promega's proprietary reagent kits and assay products, which are sole source procured due to their specialized capabilities required to support NCATS' ongoing laboratory research and high-throughput screening programs. This award was not...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed price purchase order to Revvity Health Sciences, Inc. for the purchase of two reagent kits: the HTRF cAMP Gi Assay kit and the HTRF cAMP Gs Dynamic Assay kit. The total potential value of the award is $243,665.00. These kits will be used by NCATS' Tox21 group to screen a library of 10,000 compounds as part of a cross-partner project...
This federal contract award, with a total ceiling value of $36,320.00, was made by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract was awarded to the prime contractor 10X Genomics, Inc. on December 19, 2024 and is for the procurement of 10X Genomics' Chromium X platform and associated single-cell analysis kits and reagents. This is a firm fixed-price...
This federal contract award is for the purchase of Cisbio Pro-Collagen Type 1 (Human) Kits and Alpha-SMA Assay Kits by the National Center for Advancing Translational Sciences (NCATS), a center within the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services (HHS). The $79,533.50 firm-fixed-price purchase order was awarded to Cisbio US, Inc., a foreign-owned for-profit company, and was not set aside for any small business category. The kits are being procured to support a TRND Relaxin FIU project at NCATS focused on measuring type 1 collagen as a marker for inflammation. The original pre-solicitation indicated a requirement for 12 assay kits total - 6 Pro-Collagen Type 1 (Human) kits and 6 Alpha-SMA kits.